Batimastat matrix metalloproteinase inhibitor: Began Phase II trial

British Bio-technology Group plc (BBIOY), U.K. Product: Batimastat matrix metalloproteinase inhibitor, a blocker of the enzymes cancer cells use to digest connective tissue between cells to allow tumo...